Rannikko S - Search Results

1

Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

Finne P, Auvinen A, Koistinen H, Zhang WM, Määttänen L, Rannikko S, Tammela T, Seppälä M, Hakama M, Stenman UH. Finne P, et al. Among authors: rannikko s. J Clin Endocrinol Metab. 2000 Aug;85(8):2744-7. doi: 10.1210/jcem.85.8.6725. J Clin Endocrinol Metab. 2000. PMID: 10946875 Clinical Trial.

2

Family history and prostate cancer screening with prostate-specific antigen.

Mäkinen T, Tammela TL, Stenman UH, Määttänen L, Rannikko S, Aro J, Juusela H, Hakama M, Auvinen A. Mäkinen T, et al. Among authors: rannikko s. J Clin Oncol. 2002 Jun 1;20(11):2658-63. doi: 10.1200/JCO.2002.05.006. J Clin Oncol. 2002. PMID: 12039927 Clinical Trial.

3

Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.

Finne P, Auvinen A, Aro J, Juusela H, Määttänen L, Rannikko S, Hakama M, Tammela TL, Stenman UH. Finne P, et al. Among authors: rannikko s. Eur Urol. 2002 Jun;41(6):619-26; discussion 626-7. doi: 10.1016/s0302-2838(02)00179-3. Eur Urol. 2002. PMID: 12074779 Clinical Trial.

4

Tumor characteristics in a population-based prostate cancer screening trial with prostate-specific antigen.

Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A. Mäkinen T, et al. Among authors: rannikko s. Clin Cancer Res. 2003 Jul;9(7):2435-9. Clin Cancer Res. 2003. PMID: 12855615

5

Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial.

Auvinen A, Määttänen L, Finne P, Stenman UH, Aro J, Juusela H, Rannikko S, Tammela TL, Hakama M. Auvinen A, et al. Among authors: rannikko s. Int J Cancer. 2004 Oct 10;111(6):940-3. doi: 10.1002/ijc.20352. Int J Cancer. 2004. PMID: 15300807 Clinical Trial.

6

Characterization and immunological determination of the complex between prostate-specific antigen and alpha2-macroglobulin.

Zhang WM, Finne P, Leinonen J, Vesalainen S, Nordling S, Rannikko S, Stenman UH. Zhang WM, et al. Among authors: rannikko s. Clin Chem. 1998 Dec;44(12):2471-9. Clin Chem. 1998. PMID: 9836714

7

European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Määttänen L, Auvinen A, Stenman UH, Rannikko S, Tammela T, Aro J, Juusela H, Hakama M. Määttänen L, et al. Among authors: rannikko s. Br J Cancer. 1999 Mar;79(7-8):1210-4. doi: 10.1038/sj.bjc.6690194. Br J Cancer. 1999. PMID: 10098761 Free PMC article. Clinical Trial.

8

[Why screen for prostate cancer in Finland?].

Auvinen A, Hakama M, Rannikko S, Stenman UH, Tammela T. Auvinen A, et al. Among authors: rannikko s. Duodecim. 1996;112(14):1241-3. Duodecim. 1996. PMID: 10596093 Finnish. No abstract available.

9

Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.

Finne P, Finne R, Auvinen A, Juusela H, Aro J, Määttänen L, Hakama M, Rannikko S, Tammela TL, Stenman U. Finne P, et al. Among authors: rannikko s. Urology. 2000 Sep 1;56(3):418-22. doi: 10.1016/s0090-4295(00)00672-5. Urology. 2000. PMID: 10962306 Clinical Trial.

10

Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.

Finne P, Zhang WM, Auvinen A, Leinonen J, Määttänen L, Rannikko S, Tammela TL, Stenman UH. Finne P, et al. Among authors: rannikko s. J Urol. 2000 Dec;164(6):1956-60. J Urol. 2000. PMID: 11061890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters